Pradžia › Prostatos vėžys › Minesota › Minneapolis
Prostatos vėžys klinikiniai tyrimai Minneapolis, MN
23 tyrimai dėl Prostatos vėžys ieško dalyvių vietose Minneapolis ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.
Oficialus tyrimo tekstas (anglų kalba)
Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · už 5 mylių
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Renkami dalyviai2 fazė
- Health Partners Frauenshuh Cancer Center, Saint Louis Park · už 5 mylių
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Renkami dalyviai2 fazė
- Hennepin County Medical Center, Minneapolis
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Renkami dalyviai1 fazė
- University Of Minnesota, Minneapolis
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
Renkami dalyviai1 fazė
- M Health Fairview Clinics and Surgery Center, Minneapolis
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Renkami dalyviai3 fazė
- HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0072), Saint Louis Park · už 5 mylių
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Renkami dalyviai3 fazė
- Minnesota Oncology Hematology PA, Minneapolis
- University of Minnesota Medical Center Fairview, Minneapolis
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Renkami dalyviai2 fazė
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Renkami dalyviai3 fazė
- HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0032), Saint Louis Park · už 5 mylių
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Renkami dalyviai3 fazė
- Abbott-Northwestern Hospital, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · už 5 mylių
The Vanguard Study: Testing a New Way to Screen for Cancer
Renkami dalyviaiLaukiami sveiki savanoriai
- Minneapolis VA Medical Center, Minneapolis
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
Renkami dalyviai1/2 fazė
- Research Site, Minneapolis
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
Renkami dalyviai2 fazė
- Masonic Cancer Center, Minneapolis
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Renkami dalyviai3 fazė
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- ir dar 1
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Renkami dalyviai1/2 fazė
- M Health Fairview University of Minnesota Medical Center, Minneapolis
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Renkami dalyviai1 fazė
- University of Minnesota Medical Center, Minneapolis
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Renkami dalyviai1 fazė
- Minnesota Oncology Hematology, Minneapolis
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
Renkami dalyviai1 fazė
- University of Minnesota, Minneapolis
Axelopran for Advanced Cancer in Patients Receiving Opioids
Renkami dalyviai2 fazė
- HealthPartners Frauenshuh Cancer Research Center, Saint Louis Park · už 5 mylių
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Renkami dalyviai3 fazė
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- ir dar 1
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
- Allina Health Cancer Institute, Minneapolis
Vitamin D for Prostate Endocrine Therapy
Renkami dalyviai3 fazė
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · už 5 mylių
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Renkami dalyviai3 fazė
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · už 5 mylių
Prostatos vėžys tyrimai kituose miestuose
- New York City, NY103 tyrimai
- Houston, TX76 tyrimai
- Los Angeles, CA61 tyrimas
- Boston, MA59 tyrimai
- St. Louis, MO46 tyrimai
- Chicago, IL45 tyrimai
- San Francisco, CA45 tyrimai
- Philadelphia, PA44 tyrimai
- Baltimore, MD43 tyrimai
- Nashville, TN42 tyrimai
- Seattle, WA42 tyrimai
- Washington, DC38 tyrimai
Kiti tyrimai Minneapolis
- Krūties vėžys27 tyrimai
- Nedidelinių ląstelių plaučių vėžys26 tyrimai
- Kiaušidžių vėžys24 tyrimai
- Vėžys (visų tipų)22 tyrimai
- Širdies nepakankamumas21 tyrimas
- Plaučių vėžys20 tyrimai
- Ūmi mieloidinė leukemija20 tyrimai
- Storosios ir tiesiosios žarnos vėžys19 tyrimai
- Endometrio vėžys18 tyrimai
- Parkinsono liga17 tyrimai
- Širdies ir kraujagyslių ligos15 tyrimai
- Širdies vainikinių arterijų liga13 tyrimai
Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.